17β-estradiol regulates giant vesicle formation via estrogen receptor-alpha in human breast cancer cells

Oncotarget

Volumn 5, Issue 10, 2014, Pages 3055-3065

  Wright, Paul K ^a   Jones, Sarah Bowen ^b   Ardern, Nicholas ^b   Ward, Rebecca ^b   Clarke, Robert B ^b   Sotgia, Federica ^b   Lisanti, Michael P ^b   Landberg, Goran ^b,c   Lamb, Rebecca ^b  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Breast cancer; Estrogen; Exocytosis; Trafficking; Vesicle

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; TAMOXIFEN; ESTROGEN; ESTROGEN RECEPTOR ALPHA, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER CELL LINE; BREAST CARCINOMA; CELL LABELING; CELL MIGRATION; CELL NUCLEUS; CELL SIZE; CELL SIZING (MEASUREMENT); CELL VACUOLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOLOGY; CYTOPLASM; DIFFERENTIAL INTERFERENCE CONTRAST MICROSCOPY IMAGING; FEMALE; FLUORESCENCE IMAGING; GIANT EXTRACELLULAR VESICLE; GIANT INTRACELLULAR VESICLE; GIANT VESICLE FORMATION; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGING AND DISPLAY; MOUSE; NONHUMAN; TIME LAPSE IMAGING; VALIDATION STUDY; XENOGRAFT; ANIMAL; BIOSYNTHESIS; BREAST TUMOR; CONFOCAL MICROSCOPY; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; METABOLISM; NUDE MOUSE; PAGET NIPPLE DISEASE; PATHOLOGY; TRANSPORT VESICLE; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL LINE, TUMOR; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; HETEROGRAFTS; HUMANS; MICE; MICE, NUDE; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; TRANSFECTION; TRANSPORT VESICLES;

EID: 84902084037     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.1824     Document Type: Article

References (41)

1. Osborne CK and Schiff R. Estrogen-receptor biology: continuing progress and therapeutic implications. J Clin Oncol. 2005; 23(8): 1616-1622.
2. Doisneau-Sixou SF, Sergio CM, Carroll JS, Hui R, Musgrove EA, Sutherland RL. Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells. Endocr Relat Cancer. 2003; 10(2): 179-186.
3. Cunliffe HE, Ringner M, Bilke S, Walker RL, Cheung JM, Chen Y, Meltzer PS. The gene expression response of breast cancer to growth regulators: patterns and correlation with tumor expression profiles. Cancer Res. 2003; 63(21): 7158-7166.
4. Basu A, Rowan BG. Genes related to estrogen action in reproduction and breast cancer. Front Biosci. 2005; 10: 2346-2372.
5. Deroo BJ, Korach KS. Estrogen receptors and human disease. J Clin Invest. 2006; 116(3): 561-570.
6. Vic P, Vignon F, Derocq D, Rochefort H. Effect of estradiol on the ultrastructure of the MCF7 human breast cancer cells in culture. Cancer Res. 1982; 42(2): 667-673.
7. Wright PK, May FEB, Darby S, Saif R, Lennard TWJ, Westley BR. Estrogen regulates vesicle trafficking gene expression in EEF-3, EFM-19 and MCF-7 breast cancer cells. Int J Clin Exp Pathol. 2009; 2(5): 463-475.
8. Frasor J, Stossi F, Danes SM, Komm B, Lyttle R, Katzenellenbogen BS. Selective estrogen receptor modulators: discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells. Cancer Res. 2004; 64(4): 1522-1533.
9. Mello-Grand M, Singh V, Ghimenti C, Scatolini M, Regolo L, Grosso E, Zambelli A, Da Prada GA, Villani L, Fregoni V, Baiardi P, Marsoni S, Miller WR, Costa A, Chiorino G. Gene expression profiling and prediction of response to hormonal neoadjuvant treatment with anastrozole in surgically resectable breast cancer. Breast Cancer Res Treat. 2010; 121(2): 399-411.
10. Wright PK. Targeting vesicle trafficking: An important approach to cancer chemotherapy. Recent Pat Anti-Cancer Drug Discov. 2008; 3(2): 137-147.
11. Recchi C, Seabra MC. Novel functions for Rab GTPases in multiple aspects of tumour progression. Biochem Soc Trans. 2012; 40(6): 1398-1403.
12. Subramani D, Alahari SK. Integrin-mediated function of Rab GTPases in cancer progression. Mol Cancer. 2010; 9: 312. doi: 10.1186/1476-4598-9-312.
13. Mosesson Y, Mills GB, Yarden Y. Derailed endocytosis: an emerging feature of cancer. Nat Rev Cancer. 2008; 8(11): 835-850.
14. Chan AM, Weber T. A putative link between exocytosis and tumor development. Cancer Cell. 2002; 2(6): 427-428.
15. Palmer RE, Lee SB, Wong JC, Reynolds PA, Zhang H, Truong V, Oliner JD, Gerald WL, Haber DA. Induction of BAIAP3 by EWS-WT1 chimeric fusion implicates regulated exocytosis in tumorigenesis. Cancer Cell. 2002; 2(6): 497-505.
16. Maschler S, Gebeshuber CA, Wiedemann E, Alacakaptan M, Schreiber M, Custic I, Beug H. Annexin A1 attenuates EMT and metastatic potential in breast cancer. EMBO Mol Med. 2010; 2(10): 401-414.
17. Blackman B, Russell T, Nordeen SK, Medina D, Neville MC. Claudin 7 expression and localization in the normal murine mammary gland and murine mammary tumors. Breast Cancer Res. 2005; 7(2): R248-R255.
18. Vadlamudi RK, Wang R, Talukdur AH, Adam L, Johnson R, Kumar R. Evidence of Rab3A expression, regulation of vesicle trafficking, and cellular secretion in response to heregulin in mammary epithelial cells. Mol Cell Biol. 2000; 20(23): 9092-9101.
19. Yang PS, Yin PH, Tseng LM, Yang CH, Hsu CY, Lee MY, Horng CF, Chi CW. Rab5A is associated with axillary lymph node metastasis in breast cancer patients. Cancer Sci. 2011; 102(12): 2172-2178.
20. Shan J, Mason JM, Yuan L, Barcia M, Porti D, Calabro A, Budman D, Vinciguerra V, Xu H. Rab6c, a new member of the rab gene family, is involved in drug resistance in MCF7/AdrR cells. Gene. 2000; 257(1): 67-75.
21. Bravo-Cordero JJ, Marrero-Diaz R, Megiaz D, Genis L, Garcia-Grande A, Garcia MA, Arroyo AG, Montoya MC. MT1-MMP proinvasive activity is regulated by a novel Rab8-dependent exocytic pathway. EMBO J. 2007; 26(6): 1499-1510.
22. Zhang J, Liu X, Datta A, Govindarajan K, Tam WL, Han J, George J, Wong C, Ramnarayanan K, Phua TY, Leong WY, Chan YS, Palanisamy N, Liu ET, Karuturi KM, Lim B, Miller LD. RCP is a human breast cancer-promoting gene with Ras-activating function. J Clin Invest. 2009; 119(8): 2171-2183.
23. Yin YX, Shen F, Pei H, Ding Y, Zhao H, Zhao M, Chen Q. Increased expression of Rab25 in breast cancer correlates with lymphatic metastasis. Tumor Biol. 2012; 33(5): 1581-1587.
24. Cheng KW, Lahad JP, Kuo WL, Lapuk A, Yamada K, Auersperg N, Liu J, Smith-McCune K, Lu KH, Fishman D, Gray JW, Mills GB. The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers. Nat Med. 2004; 10(11): 1251-1256.
25. Cheng JM, Volk L, Janaki DK, Vyakaranam S, Ran S, Rao KA. Tumour suppressor function of Rab25 in triple-negative breast cancer. Int J Cancer. 2010; 126(12): 2799-2812.
26. Montrel V, Huang TY, Mose E, Pestonjamasp K, Tarin D. Expression profiling of primary tumors and matched lymphatic and lung metastases in a xenogeneic breast cancer model. Am J Path. 2005; 166(5): 1565-1579.
27. Wang JS, Wang FB, Zhang QG, Shen ZZ, Shao ZM. Enhanced expression of Rab27A gene by breast cancer cells promoting invasiveness and the metastasis potential by secretion of insulin-like growth factor-II. Mol Cancer Res. 2008; 6(3): 372-382.
28. Hendrix A, Maynard D, Pauwels P, Braems G, Denys H, Van den Broecke R, Lambert J, Van Belle S, Cocquyt V, Gespach C, Bracke M, Seabra MC, Gahl WA, De Wever O, Westbroek W. Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion and metastasis. J Natl Cancer Inst. 2010; 102(12): 866-880.
29. Grismayer B, Solch S, Seubert B, Kirchner T, Schafer S, Baretton G, Schmitt M, Luther T, Kruger A, Kotzsch M, Magdolen V. Rab31 expression levels modulate tumor-relevant characteristics of breast cancer cells. Mol Cancer. 2012; 11; 62. doi: 10.1186/1476-4598-11-62.
30. Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak MZ. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia. 2006; 20(9): 1487-1495.
31. van der Pol E, Boing AN, Harrison P, Sturk A, Nieuwland R. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev. 2012; 64(3): 676-705.
32. Hugel B, Martinez MC, Kunzelmann C, Freyssinet JM. Membrane microparticles: two sides of the coin. Physiology (Bethesda). 2005; 20: 22-27.
33. Muralidharan-Chari V, Clancy JW, Sedgwick A, D'Souza-Schorey C. Microvesicles: mediators of extracellular communication during cancer progression. J Cell Sci. 2010; 123(10): 1603-1611.
34. Gyorgy B, Szabo TB, Pasztoi M, Pal Z, Misjak P, Aradi B, Laszlo V, Pallinger E, Pap E, Kittel A, Nagy G, Falus A, Buzas EI. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci. 2011; 68(16): 2667-2688.
35. Rak J. Extracellular vesicles-biomarkers and effectors of the cellular interactome in cancer. Front Pharmacol. 2013; 4:21. doi: 10.3389/fphar.2013.00021.
36. Di Vizio D, Morello M, Dudley AC, Schow PW, Adam RM, Morley S, Mulholland D, Rotinen M, Hager MH, Insabato L, Moses MA, Demichelis F, Lisanti MP, Wu H, Klagsbrun M, Bhowmick NA, Rubin MA, D'Souza-Schorey C, Freeman MR. Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease. Am J Pathol. 2012; 181(5): 1573-1584.
37. Falchi AM, Sogos V, Saba F, Piras M, Congiu T, Piludu M. Astrocytes shed large membrane vesicles that contain mitochondria, lipid droplets and ATP. Histochem Cell Biol. 2013; 139(2): 221-231.
38. Tulusan AH, Hamann M, Prestele H, Ramming I, von Maillot K, Egger H. Correlations of the receptor content and ultrastructure of breast cancer cells. Arch Gynecol. 1982; 231(3): 177-84.
39. Yabuki A, Suzuki S, Matsumoto M, Nishinakagawa H. Effects of sex hormones of the development of giant lysosomes in the proximal tubules of DBA/2Cr mouse kidney. J Anat 2003. 202(5): 445-452.
40. Machado JD, Alonso C, Morales A, Gomez JF, Borges R. Nongenomic regulation of the kinetics of exocytosis by estrogens. J Pharmacol Exp Ther 2002; 301(2): 631-637.
41. Cottu P, Marangoni E, Assayag F, de Cremoux P, Vincent-Salomon A, Guyader Ch, de Plater L, Elbaz C, Karboul N, Fontaine JJ, Chateau-Joubert S, Boudou-Rouquette P, Alran S, Dangles-Marie V, Gentien D, Poupon MF, Decaudin D. Modeling of response to endocrine therapy in a panel of luminal breast cancer xenografts. Breast Cancer Res Treat. 2012; 133(2): 595-606.